The first clinical case of a mutation at residue K185 of Kir6.2 (KCNJ11): a major ATP-binding residue.
BACKGROUND: Closure of the adenosine triphosphate (ATP)-sensitive potassium (K(ATP)) channel plays a key role in insulin secretion from the pancreatic beta-cells. Many mutations in KCNJ11 and ABCC8, which respectively encode the pore-forming (Kir6.2) and regulatory (SUR1) subunits of the K(ATP) cha...
Autori principali: | Shimomura, K, de Nanclares, G, Foutinou, C, Caimari, M, Castaño, L, Ashcroft, F |
---|---|
Natura: | Journal article |
Lingua: | English |
Pubblicazione: |
2010
|
Documenti analoghi
Documenti analoghi
-
Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes.
di: Girard, C, et al.
Pubblicazione: (2006) -
Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects.
di: Shimomura, K, et al.
Pubblicazione: (2006) -
Identification of residues contributing to the ATP binding site of Kir6.2.
di: Trapp, S, et al.
Pubblicazione: (2003) -
An in-frame deletion in Kir6.2 (KCNJ11) causing neonatal diabetes reveals a site of interaction between Kir6.2 and SUR1.
di: Craig, T, et al.
Pubblicazione: (2009) -
The role of lysine 185 in the kir6.2 subunit of the ATP-sensitive channel in channel inhibition by ATP.
di: Reimann, F, et al.
Pubblicazione: (1999)